Target intelligence / Profile preview

Streptococcus mutans dental biofilm (S. mutans biofilm)

Target
S. mutans biofilm
Molecular classification
Other (Microbial Biofilm), Extracellular polymeric substance matrix
01

Overview

Streptococcus mutans dental biofilm, commonly known as dental plaque, is a complex, structured community of microorganisms embedded in a self-produced matrix of extracellular polymeric substances (EPS) on the tooth surface. S. mutans is the primary etiologic agent of dental caries due to its ability to synthesize glucans from dietary sucrose via glucosyltransferases, which facilitates firm adherence to the teeth and provides a scaffold for other microbes (Bowen et al., 2018). Within this protected biofilm environment, S. mutans ferments carbohydrates to produce lactic acid, leading to a localized drop in pH that demineralizes tooth enamel (Loesche, 1986). Therapeutic strategies targeting this biofilm aim to disrupt its formation, neutralize acid production, or eliminate the bacteria using antimicrobial agents like chlorhexidine and fluoride. However, the dense EPS matrix often limits drug penetration, making the biofilm significantly more resistant to treatment than planktonic cells (Koo et al., 2017). Furthermore, S. mutans can enter the bloodstream during dental procedures, potentially leading to infective endocarditis, where it forms biofilms on heart valves (Lemos et al., 2019).

Other names
Dental plaqueCariogenic biofilmOral biofilmS. mutans-mediated biofilm
02

Mechanism of action

Therapeutic agents target the S. mutans dental biofilm through various mechanisms: chlorhexidine acts as a broad-spectrum antiseptic by disrupting bacterial cell membranes; fluoride inhibits the glycolytic enzyme enolase to reduce acid production and promotes enamel remineralization; xylitol interferes with the transport and metabolism of sucrose, reducing the production of sticky extracellular polysaccharides; and other agents may inhibit glucosyltransferases (GTFs) to prevent the assembly of the biofilm matrix (Koo et al., 2013; Marquis, 1995; Jones, 1997).

03

Biological functions

AdhesionAcidogenesisAciduricityExtracellular polysaccharide synthesisQuorum sensing
04

Disease associations

InfectionOther (Infective endocarditis)
05

Safety considerations

Oral dysbiosisExtrinsic tooth stainingFluorosisDevelopment of antimicrobial resistanceTaste alteration
06

Interacting drugs

Chlorhexidine

5 more in the full profile.

07

Biomarkers

S. mutans colony forming units (CFU)Biofilm pHLactic acid concentrationGlucosyltransferase activity

Beyond the preview

Go deeper on Streptococcus mutans dental biofilm (S. mutans biofilm).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus mutans dental biofilm (S. mutans biofilm).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call